While CBG has been identified as being regulated by metabolic factors such as obesity and insulin secretion51,52, there is little evidence from humans with CBG null mutations or from mice lacking CBG that deficiency alters cardiometabolic risk. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.